Clarifoam EF Top
Generic Name: SODIUM SULFACETAMIDE/SULFUR FOAM - TOPICAL
Pronounced: (SO-dee-um sull-fuh-SEET-uh-mide/SULL-fur)
Clarifoam EF Top Uses
This medication is used to treat several skin problems
(acne, rosacea, seborrheic dermatitis). Sodium sulfacetamide belongs to a class
of drugs known as sulfa antibiotics. It works by killing certain bacteria on
the skin that can lead to acne and other problems. The sulfur in this product
helps to remove dead skin and unclog pores.
How To Use Clarifoam EF Top
Follow all directions on the product package. If you are
uncertain about any of this information, consult your doctor or
pharmacist.
Use this medication on the skin only. To avoid irritation,
do not let this medication come into contact with your eyes, nose, mouth, or
any broken skin (e.g., cuts, scrapes, rashes). If you do get the medication in
those areas, flush the area with cool water. Wash your hands with soap and
water after each application.
Clean the area of skin with a mild cleanser and pat dry.
Shake the container well before each use. You may need to prime the container
before first use by pressing down for 3 to 5 seconds until foam appears. Follow
the package directions. Holding the can upright, apply a small amount of foam
on the fingertips and massage the foam into the affected area. Wait 10 minutes.
Rinse the area well with water and pat dry. Your doctor may direct you not to
wash the foam off. In that case, massage the foam into the affected area and
wipe off any extra foam.
Use this product usually 1 to 3 times daily or as directed
by your doctor. Dosage is based on your medical condition and response to
treatment.
Use this medication regularly to get the most benefit from
it. To help you remember, use it at the same time(s) each day. Do not use more
of this medication, use it more frequently, or keep using it for longer than
prescribed. Your skin will not improve any faster, and your risk of side
effects may be increased.
Tell your doctor if your acne does not improve or if it
worsens.
| 
Email this page
Printer friendly
Bookmark this page
